New AI Model Designed to Speed Up Drug Discovery
新一代人工智慧模型旨在加速藥物研發
In 2026, the landscape of medicine is changing rapidly.
2026年，醫學領域正在發生劇烈的變化。
Rather than relying on slow, physical trial-and-error, scientists now use AI to simulate and design potential medicines on computers.
科學家不再依賴緩慢的物理實驗錯誤試驗，而是利用AI在電腦上模擬並設計潛在的藥物。
Tools like AlphaFold allow researchers to understand protein structures, while generative models create new drug-like molecules from scratch.
像AlphaFold這類的工具讓研究人員能理解蛋白質結構，而生成式模型則能從零開始創造出類似藥物的新分子。
Crucially, AI is not meant to replace human experts.
關鍵在於，AI並非為了取代人類專家。
By combining human expertise with computational speed, the pharmaceutical industry is moving toward a more efficient future.
透過結合人類的專業知識與運算速度，製藥產業正邁向更有效率的未來。
Ultimately, this synergy between biology, chemistry, and AI is accelerating the path to life-saving treatments for patients worldwide.
歸根結柢，生物學、化學與AI之間的協同作用，正在加速全球病患獲得救命療法的進程。
